𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter

✍ Scribed by Rudi Bao; Muthu Selvakumaran; Thomas C. Hamilton

Book ID
112248775
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
97 KB
Volume
84
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The secretory leukoprotease inhibitor (S
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy
✍ Shannon D. Barker; Candace J. Coolidge; Anna Kanerva; Tanja Hakkarainen; Masato πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

## Abstract ## Background Adenoviruses allow efficient transduction of dividing and non‐dividing cells and their safety for the treatment of cancer has been established in clinical trials. However, one disadvantage is their promiscuous tropism. In this regard, tissue‐specific promoters (TSPs) coul

HMGA2 gene is a promising target for ova
HMGA2 gene is a promising target for ovarian cancer silencing therapy
✍ Anastasia Malek; Elena Bakhidze; Aurelia Noske; Christine Sers; Achim Aigner; Re πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 662 KB

## Abstract Ovarian cancer is one of the most lethal gynecological malignancies and the small success rate of routine therapeutic methods justifies efforts to develop new approaches. Evaluation of targets for effective inhibition of ovarian cancer cell growth should precipitate clinical application